1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2017The Kiplinger Washington Editors
These market laggards have the potential to pay off big if investors' pessimism proves to be overblown.
Fairholme, a superb fund, is shifting out of commodities and into drug stocks and managed-care companies. The timing looks perfect.
With savvy, conservative management, Fairholme fund knows how to make money and keep risks low.
More Investing News »